arrow
J

João Pedro Ferrari-Souza

universidade federal do rio grande do sul
H指数:18
被引数:1,706

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Spatiotemporal dynamics of tau extent and load increase in Alzheimer’s disease across four longitudinal cohorts

阿尔茨海默病中tau蛋白范围和负荷增加的时空动态变化:基于四项纵向队列研究

2026-07-140
OAAI
Microglia as a key player in Aβ‐related astrocyte reactivity

小胶质细胞作为Aβ相关星形胶质细胞反应性的关键参与者

2025-12-250
OAAI
In vivo-measured Lewy body pathology is associated with neuropsychiatric symptoms across the Alzheimer’s disease continuum

体内测量的路易体病理与阿尔茨海默病连续谱系中的神经精神症状相关

2025-12-140
PRE
APOE ε4 potentiates tau related reactive astrogliosis assessed by cerebrospinal fluid YKL40 in Alzheimer’s disease

APOE ε4 增强阿尔茨海默病中与tau蛋白相关的反应性星形胶质细胞增生,该增生通过脑脊液YKL40进行评估。

2025-11-200
OA
Microglia modulate Aβ-dependent astrocyte reactivity in Alzheimer’s disease

小胶质细胞调节阿尔茨海默病中Aβ依赖性的星形胶质细胞反应性

2025-11-060
OAAI
Amyloid beta and tau are associated with the dual effect of neuroinflammation on neurodegeneration

A Amyloid beta和tau与神经炎症对神经退行性病变的双效作用相关。Alzheimers. Dement. 21:e70746

2025-09-292
OAAI
Reversible tau hyperphosphorylation in hibernation: a blood biomarker and brain tissue study

冬眠期间可逆的tau过度磷酸化:一项血液生物标志物和脑组织研究

2025-09-290
OAAI
Diagnostic performance of Alzheimer’s disease blood and CSF biomarkers in a Brazilian cohort with low educational attainment

阿尔茨海默病血液和脑脊液生物标志物在巴西低教育程度队列中的诊断性能

2025-09-080
PRE
CSF total tau as a proxy of synaptic degeneration

脑脊液总tau蛋白作为突触退行性变的替代指标

2025-08-290
OAAI
Glial reactivity correlates with synaptic dysfunction across aging and Alzheimer’s disease

Rohden, F, Ferreira, PCL, Bellaver, B, Ferrari-Souza, JP, Aguzzoli, CS, Soares, C, et al. 胶质细胞反应性与老化及阿尔茨海默病中的突触功能障碍相关。Nat Commun. (2025) 16:5653. doi: 10.1038/s41467-025-60806-1

2025-07-010
OAAI
Impact of the polygenic risk scores for attention-deficit/hyperactivity disorder in Alzheimer's disease

注意缺陷多动障碍多基因风险评分对阿尔茨海默病的影响

2025-02-250
OAAI
Exploring the utility of Plasma GFAP as a secondary endpoint in Alzheimer's disease Clinical trials to monitor disease progression

探索血浆GFAP作为阿尔茨海默病临床试验中监测疾病进展的次要终点指标的应用价值

2025-01-090
OA
Modeling the progression of neuropsychiatric symptoms in Alzheimer's disease with PET-based Braak staging
2024-12-011
OAAI
Influence of Different Diagnostic Criteria on Alzheimer Disease Clinical Research
2024-09-102
PRE
Vascular risk burden is a key player in the early progression of Alzheimer's disease
2024-04-019
OAAI
Predicting functional decline in aging and Alzheimer's disease with PET-based Braak staging
2024-02-264
OAAI